Archive for July, 2009
« Previous EntriesFDA approves Lilly’s Forteo for patients taking glucocorticoids for inflammatory conditions.
Friday, July 24th, 2009The AP (7/24) reports, “Drugmaker Eli Lilly and Co. said Thursday regulators have approved a new use for its osteoporosis treatment Forteo [teriparatide].” The drug was approved “as treatment for patients taking” glucocorticoid “medications for inflammatory conditions like rheumatoid arthritis and obstructive pulmonary disease.” Forteo is “already…approved to treat osteoporosis in men and women.”
[…]
HAART Sharply Cuts Mother-to-Child HIV Risk
Thursday, July 23rd, 2009Antiretroviral therapy starting in the third trimester of pregnancy continuing through six months of breastfeeding sharply reduces the risk of mother-to-child HIV transmission, a researcher said here.
The protection carries through at least six months of breastfeeding, a practice that has important health benefits in resource-poor societies, according to Roger Shapiro, MD, of Harvard Medical […]
Longer HAART Use Predicts Hepatitis B Clearance
Thursday, July 16th, 2009In patients with both HIV and hepatitis B, prolonged use of drugs active against both viruses improves the odds of clearing the hepatitis, researchers said.
In a retrospective, longitudinal study, patients who were on such highly active antiretroviral therapy (HAART) for a longer period had nearly three times the likelihood of clearing the HBeAg antigen […]
New drugs, better understanding of migraines seen as improving therapy.
Monday, July 13th, 2009New drugs, better understanding of migraines seen as improving therapy.
USA Today (7/13, Marcus) reports, “Newer drug treatments and a better understanding of the living and environmental factors that influence migraines have given people better tools to help reduce episodes and treat the pain.” According to J.D. Bartleson, associate professor of neurology in the Mayo Clinic’s […]
Finasteride Does Not Cause Aggressive Forms Of Prostate Cancer But Makes Them Easier To Diagnose
Sunday, July 12th, 2009Whether to treat men at risk of prostate cancer with the drug finasteride has been the dilemma with doctors for the last six years. On one hand, the drug had been shown to prevent cancer in about one of every four patients who received it. On the other, those who did develop cancer while on […]
« Previous Entries
